Duoneb and Sputum discolored - a phase IV clinical study of FDA data

Summary:

Sputum discolored is reported as a side effect among people who take Duoneb (albuterol sulfate; ipratropium bromide), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zithromax, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Sputum discolored when taking Duoneb. It is created by eHealthMe based on reports of 8,008 people who have side effects when taking Duoneb from the FDA, and is updated regularly.

What is Duoneb?

Duoneb has active ingredients of albuterol sulfate; ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 8,093 Duoneb users. Check the latest studies of Duoneb.

What is Sputum discolored?

Sputum discolored is found to be associated with 915 drugs and 552 conditions by eHealthMe. Check the latest studies of Sputum discolored.

On Jul, 10, 2026

8,008 people reported to have side effects when taking Duoneb.
Among them, 45 people (0.56%) have Sputum discolored.

Among these 45 people:

How long have people been on Duoneb when they have Sputum discolored? *

What is the gender of people who have Sputum discolored when taking Duoneb? *

female: 55.56 %
male: 44.44 %

What is the age of people who have Sputum discolored when taking Duoneb? *

What are other drugs people take besides Duoneb? *

What are other side effects people have besides Sputum discolored? *

Dyspnea (difficult or laboured breathing): 38 people, 84.44%
Productive Cough: 31 people, 68.89%
Cough: 29 people, 64.44%
Pneumonia: 23 people, 51.11%
Wheezing (a high-pitched whistling sound made while you breath): 20 people, 44.44%
Fever: 19 people, 42.22%
Weakness: 18 people, 40.00%
Chest Pain: 16 people, 35.56%
Hypotension (abnormally low blood pressure): 15 people, 33.33%
Fatigue (feeling of tiredness): 14 people, 31.11%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 22.22%
Cystic Fibrosis (disease of the secretary glands): 8 people, 17.78%
Depression: 8 people, 17.78%
Oral Candidiasis (fungal infection of mouth): 7 people, 15.56%
Itching: 7 people, 15.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 15.56%
Sleep Disorder: 7 people, 15.56%
Wheezing (a high-pitched whistling sound made while you breath): 6 people, 13.33%
Faeces Hard: 6 people, 13.33%
Migraine (headache): 6 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Duoneb and have Sputum discolored?

- Check whether Sputum discolored is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duoneb:

Duoneb (8,093 reports)

Sputum discolored treatments and more:

Sputum discolored (13,608 reports)

How severe was Sputum discolored and when was it recovered:

Sputum discolored in Duoneb

Expand to all the drugs that have ingredients of albuterol sulfate; ipratropium bromide:

Sputum discolored and drugs with ingredients of albuterol sulfate; ipratropium bromide (93 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duoneb:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum discolored:

Sputum discolored (915 drugs)

Browse all the conditions that are associated with Sputum discolored:

Sputum discolored (552 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate; ipratropium bromide (the active ingredients of Duoneb) and Duoneb (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.